JY
OPXAW

Jeff Yass’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Jeff Yass’s Portfolio OPXAW Stock Details OPXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-256,572
Closed -$4K – 10309
2017
Q1 		$4K Buy
+256,572
New +$4.72K ﹤0.01% 8799
2016
Q4 		– Sell
-18,596
Closed -$2K – 10522
2016
Q3 		$2K Buy
+18,596
New +$1.7K ﹤0.01% 8320

Other funds holding OPXAW

VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jeff Yass's OPXAW Position: Q2 2017 in Review

Jeff Yass sold out of Opexa Therapeutics, Inc. (OPXAW) in Q2 2017, closing a stake of 256,572 shares — an estimated $4K sold.

Jeff Yass first reported a position in OPXAW in Q3 2016 and held it in 2 quarters. The position peaked at $4K in Q1 2017. 4 funds tracked by Wall St. Rank hold OPXAW as of Q2 2017.

  • Jeff Yass reported no remaining Opexa Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Jeff Yass sold 256,572 Opexa Therapeutics, Inc. shares in Q2 2017, an estimated $4K.
  • Jeff Yass first reported a position in Opexa Therapeutics, Inc. in Q3 2016 and held it in 2 quarters.
  • Jeff Yass's Opexa Therapeutics, Inc. position peaked at $4K in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q2 2017.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.